Today's special offer: Access for Free!!!

Profile
Financial Statement
- Income Statement
- Comprehensive Income
- Assets
- Liabilities and Stockholders' Equity
- Statement of Cash Flows
Common-Size
- Income Statement
- Assets
- Liabilities and Stockholders' Equity
Ratios
- Short-term Activity
- Long-term Activity
- Liquidity
- Long-term Debt and Solvency
- Profitability
- DuPont
Relative Valuation
- Ratios (Price Multiples)
- Enterprise Value (EV)
- EV to EBITDA
- EV to FCFF
- Price to FCFE
DCF
- CAPM
- DDM
- Present Value of FCFF
- Present Value of FCFE
Analysis
- Revenues
- Investments
- Inventory
- Property, Plant and Equipment
- Goodwill and Intangible Assets
- Debt
- Income Taxes
Reporting Quality
- Aggregate Accruals

Novartis AG (NVS) | Common-Size Income Statement

See also

Johnson & Johnson (JNJ), Common-Size Income Statement
Pfizer Inc. (PFE), Common-Size Income Statement
Merck & Co. Inc. (MRK), Common-Size Income Statement
GlaxoSmithKline PLC (GSK), Common-Size Income Statement
Abbott Laboratories (ABT), Common-Size Income Statement
Sanofi (SNY), Common-Size Income Statement
Novo Nordisk A/S (NVO), Common-Size Income Statement
UnitedHealth Group Inc. (UNH), Common-Size Income Statement
Bristol-Myers Squibb Co. (BMY), Common-Size Income Statement
AstraZeneca PLC (AZN), Common-Size Income Statement
Eli Lilly & Co. (LLY), Common-Size Income Statement
Medtronic Inc. (MDT), Common-Size Income Statement
Baxter International Inc. (BAX), Common-Size Income Statement

ˇ Show More

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Novartis AG, Common-Size Consolidated Income Statement

Export to Excel

Export to OpenOffice.org

		Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
	Net sales
	Other revenues
	Cost of goods sold
	Gross profit	%	%	%	%	%
	Marketing & sales
	Research & development
	General & administration
	Other income
	Other expense
	Operating income	%	%	%	%	%
	Income from associated companies
	Interest expense
	Expense due to discounting long-term liabilities
	Total interest expense	%	%	%	%	%
	Interest income
	Dividend income
	Net capital gains (losses) on available-for-sale securities
	Impairment of available-for-sale securities
	Income on options and forward contracts
	Expenses on options and forward contracts
	Other financial income
	Other financial expense
	Currency result, net
	Total other financial income (expense)	%	%	%	%	%
	Income before taxes	%	%	%	%	%
	Taxes
	Net income from continuing operations	%	%	%	%	%
	Net income from discontinued operations
	Net income	%	%	%	%	%
	Net income attributable to non-controlling interests
	Net income attributable to shareholders of Novartis AG	%	%	%	%	%

Top

Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center